Advanced Filters
noise

Aspergillosis Clinical Trials

A listing of Aspergillosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,104 clinical trials
Y Yu-Dong Zhang, MD;PHD

High Resolution Diffusion Weighted Imaging in Prostate

hrDWI might be an alternative to cDWI for the prostate imaging. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general improve the diagnostic accuracy of PCa in particular than conventional DWI

55 years of age Male Phase N/A
N Naik Vietti Violi, MD

Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)

This study compares the effectiveness of low-field MRI (0.55T) with high-field MRI (3T) in prostate cancer screening and image quality. It consists of three phases: optimizing the low-field MRI protocol with healthy volunteers, evaluating image quality in patients with metallic artifacts (like hip prostheses), and assessing low-field MRI in patients …

18 years of age Male Phase N/A
R Rishma Bhatti

In Vivo Dosimetry for Brachytherapy Study

The main study aim is the investigate the clinical use of in vivo dosimeters (small measurement devices) for brachytherapy (internal radiotherapy).

18 years of age All Phase N/A

Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

A multicentre observational study on treatment approaches and biomarkers in de novo metastatic hormone sensitive prostate cancer in Russian Federation

18 years of age Male Phase N/A
T Tao Tao, MD Ph.D

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

The purpose of this prospective, single-center, single-arm trial was to evaluate the pathologic type of re-treatment based on a clear PI-RADS score of ≥4 with a first negative prostate biopsy, belonging to the high-risk group of the USTC diagnostic model, and PSMA PET/CT positive patients, and to evaluate the diagnostic …

- 75 years of age Male Phase N/A
F Frederik Lars Giesel, Univ.-Prof. Dr. med.

Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer

The introduction of PSMA diagnostics and therapy has fundamentally changed the treatment management of prostate cancer and has significantly replaced other clinical and radiological diagnostic methods. As a result, 18F-PSMA-1007 (Radelumin®) was approved in Germany and several EU countries, most recently in Germany in 01/2024, for use in primary staging …

18 years of age Male Phase N/A
A Anne E Kiltie, Prof

Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer

The digestive tract (large intestine) contains microorganisms that digest complex carbohydrates in food to produce chemical substances which are beneficial to human health. The population of these microorganisms in faeces (stool samples) could be used to diagnose the health status of a person and this can be changed with the …

60 years of age Male Phase N/A
M Matthias Eiber, Prof.

Liquid Biopsy Under PSMA Radioligand Therapy

Prostate cancer is the second most common cause of cancer death in men worldwide. After exhausting guideline-compliant therapies or in accordance with the approval of 177Lu-PSMA-617 (Pluvicto®), patients with metastatic castration-resistant prostate cancer (mCRPC) can be offered radioligand therapy (RLT) that targets the prostate-specific membrane antigen (PSMA). Despite an initially …

years of age Male Phase N/A

Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, oncologic outcomes and urinary/sexual function, and identify predictors of complications, …

40 - 95 years of age Male Phase N/A
J Juan Javier-DesLoges, MD

Focal Therapy for Localized Prostate Cancer

This prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy. The goal of which is to improve patient care.

18 years of age Male Phase N/A

Simplify language using AI